USE OF NUCLEIC ACID-POLYSACCHARIDE COMPLEXES HAVING IMMUNOPOTENTIATING ACTIVITY AS ANTI-TUMOR DRUG

摘要

The present invention provides an anticancer agent to be used as a single agent. More specifically, the present invention provides an anticancer agent containing complexes that contain (a) an oligodeoxynucleotide containing a humanized K-type CpG oligodeoxynucleotide and polydeoxyadenylic acid, the polydeoxyadenylic acid being located on the 3' side of the humanized K-type CpG oligodeoxynucleotide, and (b) β-1,3-glucan. The present invention is preferably characterized in that the anticancer agent is administered without a cancer antigen.